Susquehanna International Group, LLP Xenon Pharmaceuticals Inc. Put Options Transaction History

Susquehanna International Group, LLP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 15, 2024	SELL	$36.25 - $43.75 $177,625 - $214,375	-4,900 Reduced 14.76%	28,300 $1.1 Million
Q1 2024 May 07, 2024	SELL	$42.66 - $50.04 $106,649 - $125,100	-2,500 Reduced 7.0%	33,200 $1.43 Million
Q4 2023 Feb 14, 2024	BUY	$28.7 - $46.46 $88,970 - $144,026	3,100 Added 9.51%	35,700 $1.64 Million
Q3 2023 Nov 14, 2023	SELL	$34.16 - $39.73 $109,311 - $127,135	-3,200 Reduced 8.94%	32,600 $1.11 Million
Q2 2023 Aug 11, 2023	BUY	$34.84 - $43.54 $1.25 Million - $1.56 Million	35,800 New	35,800 $1.38 Million
Q4 2022 Feb 14, 2023	SELL	$33.06 - $39.43 $495,900 - $591,450	-15,000 Reduced 58.37%	10,700 $421,000
Q3 2022 Nov 14, 2022	SELL	$30.79 - $39.82 $708,170 - $915,860	-23,000 Reduced 47.23%	25,700 $928,000

212

70.2M

88.3K

28.8K

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.42B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.